Tanaka K - Search Results

1

Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.

Hayashi Y, Makino T, Sato E, Ohshima K, Nogi Y, Kanemura T, Honma K, Yamashita K, Saito T, Tanaka K, Yamamoto K, Takahashi T, Kurokawa Y, Miyata H, Nakajima K, Wada H, Morii E, Eguchi H, Doki Y. Hayashi Y, et al. Among authors: tanaka k. Br J Cancer. 2023 Jun;128(12):2175-2185. doi: 10.1038/s41416-023-02235-9. Epub 2023 Apr 4. Br J Cancer. 2023. PMID: 37016103 Free PMC article.

2

[A case of chemoradiation with tissue expander for local reccurence of rectal cancer].

Tanaka K, Noura S, Ohue M, Takachi K, Kishi K, Eguchi H, Yamada T, Miyashiro I, Yano M, Ohigashi H, Sasaki Y, Ishikawa O, Imaoka S, Kameyama M, Murata K. Tanaka K, et al. Gan To Kagaku Ryoho. 2005 Oct;32(11):1779-81. Gan To Kagaku Ryoho. 2005. PMID: 16315939 Japanese.

3

[A surgical case of solitary lymph node metastatic recurrence of hepatocellular carcinoma after hepatectomy].

Tanaka K, Yamada K, Sasaki H, Kishi K, Noura S, Takachi K, Eguchi H, Miyashiro I, Ohue M, Ohigashi H, Yano M, Ishikawa O, Imaoka S. Tanaka K, et al. Gan To Kagaku Ryoho. 2006 Nov;33(12):1938-40. Gan To Kagaku Ryoho. 2006. PMID: 17212152 Japanese.

4

CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after resection in patients with esophageal cancer.

Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Shingai T, Gotoh K, Noura S, Takahashi H, Ohue M, Yamada T, Ohigashi H, Yamamoto T, Yamasaki T, Doki Y, Ishikawa O. Tanaka K, et al. Ann Surg Oncol. 2010 Oct;17(10):2779-86. doi: 10.1245/s10434-010-1075-3. Epub 2010 Apr 22. Ann Surg Oncol. 2010. PMID: 20411433

5

Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus.

Yamasaki M, Miyata H, Tanaka K, Shiraishi O, Motoori M, Peng YF, Yasuda T, Yano M, Shiozaki H, Mori M, Doki Y. Yamasaki M, et al. Among authors: tanaka k. Oncology. 2011;80(5-6):307-13. doi: 10.1159/000329806. Epub 2011 Jul 18. Oncology. 2011. PMID: 21778771 Clinical Trial.

6

Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer.

Miyata H, Yano M, Yasuda T, Hamano R, Yamasaki M, Hou E, Motoori M, Shiraishi O, Tanaka K, Mori M, Doki Y. Miyata H, et al. Among authors: tanaka k. Clin Nutr. 2012 Jun;31(3):330-6. doi: 10.1016/j.clnu.2011.11.002. Epub 2011 Dec 12. Clin Nutr. 2012. PMID: 22169459 Clinical Trial.

7

Relationship between immunological parameters and the severity of neutropenia and effect of enteral nutrition on immune status during neoadjuvant chemotherapy on patients with advanced esophageal cancer.

Motoori M, Yano M, Yasuda T, Miyata H, Peng YF, Yamasaki M, Shiraishi O, Tanaka K, Ishikawa O, Shiozaki H, Doki Y. Motoori M, et al. Among authors: tanaka k. Oncology. 2012;83(2):91-100. doi: 10.1159/000339694. Epub 2012 Jul 9. Oncology. 2012. PMID: 22777298 Clinical Trial.

8

Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.

Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y. Sugimura K, et al. Among authors: tanaka k. Clin Cancer Res. 2012 Sep 15;18(18):5144-53. doi: 10.1158/1078-0432.CCR-12-0701. Epub 2012 Jul 30. Clin Cancer Res. 2012. PMID: 22847808

9

Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.

Tanaka K, Miyata H, Yamasaki M, Sugimura K, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Tanaka K, et al. Ann Surg Oncol. 2013 Dec;20 Suppl 3:S607-15. doi: 10.1245/s10434-013-3093-4. Epub 2013 Jul 10. Ann Surg Oncol. 2013. PMID: 23838916

10

Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).

Miyata H, Yamasaki M, Takahashi T, Murakami K, Tanaka K, Yukinori K, Nakajima K, Takiguchi S, Morii E, Hatazawa J, Mori M, Doki Y. Miyata H, et al. Among authors: tanaka k. Ann Surg Oncol. 2014 Feb;21(2):575-82. doi: 10.1245/s10434-013-3343-5. Epub 2013 Nov 8. Ann Surg Oncol. 2014. PMID: 24201746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18,332 results

Search Page